Cipher Pharmaceuticals Statistics
Total Valuation
CPHRF has a market cap or net worth of 225.34 million. The enterprise value is 248.25 million.
| Market Cap | 225.34M |
| Enterprise Value | 248.25M |
Important Dates
The last earnings date was Friday, March 14, 2025.
| Earnings Date | Mar 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.79% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 14.86M |
Valuation Ratios
The trailing PE ratio is 19.52.
| PE Ratio | 19.52 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 36.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.78, with an EV/FCF ratio of -4.10.
| EV / Earnings | 21.50 |
| EV / Sales | 7.39 |
| EV / EBITDA | 20.78 |
| EV / EBIT | 31.41 |
| EV / FCF | -4.10 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.40.
| Current Ratio | 1.94 |
| Quick Ratio | 1.59 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 3.42 |
| Debt / FCF | -0.67 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.63% and return on invested capital (ROIC) is 4.38%.
| Return on Equity (ROE) | 12.63% |
| Return on Assets (ROA) | 3.95% |
| Return on Invested Capital (ROIC) | 4.38% |
| Return on Capital Employed (ROCE) | 5.50% |
| Revenue Per Employee | 6.67M |
| Profits Per Employee | 2.31M |
| Employee Count | 5 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 2.11 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.09% in the last 52 weeks. The beta is 1.14, so CPHRF's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | +28.09% |
| 50-Day Moving Average | 8.91 |
| 200-Day Moving Average | 9.67 |
| Relative Strength Index (RSI) | 50.06 |
| Average Volume (20 Days) | 17,333 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CPHRF had revenue of 33.36 million and earned 11.55 million in profits. Earnings per share was 0.46.
| Revenue | 33.36M |
| Gross Profit | 24.10M |
| Operating Income | 7.85M |
| Pretax Income | 2.96M |
| Net Income | 11.55M |
| EBITDA | 11.69M |
| EBIT | 7.85M |
| Earnings Per Share (EPS) | 0.46 |
Balance Sheet
The company has 17.84 million in cash and 40.58 million in debt, giving a net cash position of -22.74 million.
| Cash & Cash Equivalents | 17.84M |
| Total Debt | 40.58M |
| Net Cash | -22.74M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 102.34M |
| Book Value Per Share | 4.00 |
| Working Capital | 18.61M |
Cash Flow
In the last 12 months, operating cash flow was 19.55 million and capital expenditures -80.04 million, giving a free cash flow of -60.50 million.
| Operating Cash Flow | 19.55M |
| Capital Expenditures | -80.04M |
| Free Cash Flow | -60.50M |
| FCF Per Share | n/a |
Margins
Gross margin is 72.24%, with operating and profit margins of 23.52% and 34.60%.
| Gross Margin | 72.24% |
| Operating Margin | 23.52% |
| Pretax Margin | 8.86% |
| Profit Margin | 34.60% |
| EBITDA Margin | 35.04% |
| EBIT Margin | 23.52% |
| FCF Margin | n/a |
Dividends & Yields
CPHRF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.79% |
| Shareholder Yield | 0.79% |
| Earnings Yield | 5.12% |
| FCF Yield | -26.85% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CPHRF has an Altman Z-Score of 3.17.
| Altman Z-Score | 3.17 |
| Piotroski F-Score | n/a |